Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Crossref DOI link: https://doi.org/10.1186/s13058-018-0999-6
Published Online: 2018-08-30
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hutcheson, Iain R.
Knowlden, Janice M.
Hiscox, Steve E.
Barrow, Denise
Gee, Julia M. W.
Robertson, John F.
Ellis, Ian O.
Nicholson, Robert I.
Text and Data Mining valid from 2018-08-30
Article History
Received: 6 June 2018
Accepted: 6 June 2018
First Online: 30 August 2018